Company Description
Apeiron Capital Investment Corp. (APN) is a blank check company established with the primary goal of executing mergers, capital stock exchanges, asset acquisitions, stock purchases, reorganizations, or similar business combinations. Under the leadership of Chief Executive Officer Dr. Joel Shulman, the company has navigated various business ventures and strategic decisions to maximize shareholder value.
As of August 11, 2023, Apeiron Capital Investment Corp. announced its decision to terminate the Business Combination Agreement with GIO World Health, Ltd. Due to the inability to complete an initial business combination within the required timeframe, the company will liquidate and dissolve effective August 14, 2023. This decision will lead to the redemption of all outstanding public shares at a per-share price determined by the trust account funds, excluding up to $100,000 allocated for dissolution expenses. Public shares will be deemed canceled and holders will receive their redemption amounts shortly after the termination date.
The company has instructed the trustee to liquidate the trust account, with proceeds held in a non-interest bearing account until disbursement to shareholders. Founder shares issued during the initial public offering will not be redeemed, and the company's warrants will expire worthless under the current plan.
Apeiron Capital Investment Corp. has always aimed to provide transparent and effective communication with its investors. The company’s forward-looking statements have outlined potential business combinations and financing plans, which have been subject to various market conditions and regulatory factors.
With a focus on shareholder value and diligent financial management, Apeiron Capital Investment Corp. remains committed to adhering to regulatory standards and fulfilling its obligations to its stakeholders as it transitions through the liquidation process.
Stock Performance
Latest News
SEC Filings
No SEC filings available for APN.